特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
518861

高密度マルチプレックス診断検査の世界市場:2017~2021年

Global High-density Multiplexed Diagnostic Assays Market 2017-2021

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 89 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
高密度マルチプレックス診断検査の世界市場:2017~2021年
出版日: 2017年06月21日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 89 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

マルチプレックス検査とは、1回の検査過程で多数 (数十、またはそれ以上) の検査項目を同時に検査する、という検査方法です。一人の患者からの標本を用いて、様々な種類の検査が実施されます。世界の高密度マルチプレックス診断検査市場は2017~2021年にかけて、15.01%のCAGR (複合年間成長率) で成長する見通しです。

当レポートでは、世界の高密度マルチプレックス (多項目同時) 診断検査の市場について分析し、技術・サービスの概要や市場の基本構造、市場規模の動向 (今後5年間の予測値)、製品別・エンドユーザー別・地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・推計しております。

第1章 エグゼクティブ・サマリー

第2章 分析範囲

第3章 市場分析の手法

第4章 イントロダクション

  • 市場の概略

第5章 市場環境

  • 市場概要
  • 市場規模とその予測
  • ファイブフォース分析

第6章 製品別の市場区分

  • 高密度マルチプレックス診断検査 (500~10000項目)
  • 超高密度マルチプレックス診断検査 (10000項目以上)
  • 市場概要

第7章 エンドユーザー別の市場区分

  • 市場概要
  • 臨床診断試験室
  • 病院・クリニック

第8章 地域区分

  • 南北アメリカ市場
  • 欧州・中東・アフリカ諸国 (EMEA) 市場
  • アジア太平洋地域市場

第9章 意思決定フレームワーク

第10章 促進要因と課題

  • 市場促進要因
  • 感染症
  • 腫瘍
  • 自己免疫疾患
  • 心臓病
  • アレルギー
  • その他の活用分野
  • 市場の課題

第11章 市場の動向

  • 自動・マルチプレックスPCR (ポリメラーゼ連鎖反応) 検査
  • 分子POCT (ポイントオブケア検査) の普及率の高さ
  • 検出装置の感度改善
  • 病院から系列検査室への外注化

第12章 ベンダー環境

  • 競争環境の分析

第13章 主要ベンダーの分析

  • Thermo Fisher Scientific
  • Abbott
  • F. Hoffmann-La Roche
  • Key companies to watch
  • その他の有力ベンダー

第14章 付録

  • 略語集

図表一覧

図表
  • Exhibit 01: Various type of multiplex techniques
  • Exhibit 02: Global multiplexed diagnostic assays market segmentation (%)
  • Exhibit 03: Global high-density multiplexed diagnostic assays market 2016-2021: Overview
  • Exhibit 04: Global high-density multiplexed diagnostic assays market 2016-2021 ($ billions)
  • Exhibit 05: Features and benefits of personalized medicines: Market impact
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Global high-density multiplexed diagnostic assays market by product 2016
  • Exhibit 08: Global high-density multiplexed diagnostic assays market 2016-2021 ($ billions)
  • Exhibit 09: Global very high-density multiplexed diagnostic assays market 2016-2021 ($ billions)
  • Exhibit 10: Global high-density multiplexed diagnostic assays: Overview
  • Exhibit 11: Buying criteria and impact assessment: End-users
  • Exhibit 12: Global high-density multiplexed diagnostic assays market 2016-2021: Overview
  • Exhibit 13: High-density multiplexed diagnostic assays market in Americas 2016-2021: Overview
  • Exhibit 14: High-density multiplexed diagnostic assays market in Americas 2016-2021 ($ billions)
  • Exhibit 15: Americas: Market metrics in various countries
  • Exhibit 16: High-density multiplexed diagnostic assays market in EMEA 2016-2021: Overview
  • Exhibit 17: High-density multiplexed diagnostic assays market in EMEA 2016-2021 ($ billions)
  • Exhibit 18: EMEA: Market metrics in various countries
  • Exhibit 19: High-density multiplexed diagnostic assays market in APAC 2016-2021: Overview
  • Exhibit 20: High-density multiplexed diagnostic assays market in APAC 2016-2021 ($ billions)
  • Exhibit 21: APAC: Market metrics in various countries
  • Exhibit 22: Benefits of leasing instruments
  • Exhibit 23: Application and indications: High-density multiplexed diagnostic assays market 2016-2021
  • Exhibit 24: Impact assessment of various application areas
  • Exhibit 25: Competitive structure analysis of global high-density multiplexed diagnostic assays market 2016
  • Exhibit 26: Competitive landscape analysis of global high-density multiplexed diagnostic assays market 2016
  • Exhibit 27: Strategic success factors of companies in global high-density multiplexed diagnostic assays market
  • Exhibit 28: Thermo Fisher Scientific: Key highlights
  • Exhibit 29: Thermo Fisher Scientific: Strength assessment
  • Exhibit 30: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 31: Thermo Fisher Scientific: Opportunity assessment
  • Exhibit 32: Abbott: Key highlights
  • Exhibit 33: Abbott: Strength assessment
  • Exhibit 34: Abbott: Strategy assessment
  • Exhibit 35: Abbott: Opportunity assessment
  • Exhibit 36: F. Hoffmann-La Roche: Key highlights
  • Exhibit 37: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 38: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 39: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 40: bioMerieux: Company assessment
  • Exhibit 41: Illumina: Company assessment
  • Exhibit 42: Qiagen: Company assessment
  • Exhibit 43: Other prominent vendors in global high-density multiplexed diagnostic assays market
目次
Product Code: IRTNTR13589

About High Density Multiplexed Diagnostic Assays

A multiplex assay is a type of assay used in research to simultaneously measure multiple analytes (dozens or more) in a single run/cycle of the assay. It is distinguished from procedures that measure one analyte at a time. The assay is one of the diagnostic procedures performed in the laboratory, pharmacology, molecular biology, and various other medical procedures. Different types of assays are performed for the detection and diagnosis of patient's sample.

Technavio's analysts forecast the global high density multiplexed diagnostic assays market to grow at a CAGR of 15.01% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global high density multiplexed diagnostic assays market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global High density multiplexed diagnostic assays Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Thermo Fisher Scientific
  • Abbott
  • F. Hoffmann-La Roche

Other Prominent Vendors

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Erba Diagnostics
  • GOLD STANDARD DIAGNOSTICS
  • Hologic
  • Luminex
  • Randox Laboratories

Market driver

  • Increasing equipment rental agreements
  • For a full, detailed list, view our report

Market challenge

  • High cost of multiplexed diagnostic assay equipment
  • For a full, detailed list, view our report

Market trend

  • Introduction of automated multiplexed PCR assays
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • High-density multiplexed diagnostic assays (500-10,000 plex)
  • Very high-density multiplexed diagnostic assays (>10,000 plex)
  • Market overview

PART 07: Market segmentation by end-user

  • Market overview
  • Clinical diagnostic laboratories
  • Hospitals and clinics

PART 08: Geographical segmentation

  • High-density multiplexed diagnostic assays market in Americas
  • High-density multiplexed diagnostic assays market in EMEA
  • High-density multiplexed diagnostic assays market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Infectious diseases
  • Oncology
  • Autoimmune diseases
  • Cardiac diseases
  • Allergies
  • Other application areas
  • Market challenges

PART 11: Market trends

  • Introduction of automated multiplexed PCR assays
  • Higher adoption rate of molecular POCT
  • Improved sensitivity for the detection systems
  • Outsourcing from hospitals to reference laboratories

PART 12: Vendor landscape

  • Competitive landscape analysis

PART 13: Key vendor analysis

  • Thermo Fisher Scientific
  • Abbott
  • F. Hoffmann-La Roche
  • Key companies to watch
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.